LEIOMYOSARCOMA (LMS)
Clinical trials for LEIOMYOSARCOMA (LMS) explained in plain language.
Never miss a new study
Get alerted when new LEIOMYOSARCOMA (LMS) trials appear
Sign up with your email to follow new studies for LEIOMYOSARCOMA (LMS), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo aims to outsmart Hard-to-Treat cancers
Disease control Recruiting nowThis early-phase study tests an experimental drug called OKN4395, taken as a pill, alone or together with the immunotherapy pembrolizumab. The goal is to find a safe dose and see if the combination can shrink tumors in people with advanced solid cancers like lung, colorectal, sto…
Matched conditions: LEIOMYOSARCOMA (LMS)
Phase: PHASE1 • Sponsor: Epkin • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
Proton beam boost: new hope for inoperable sarcomas?
Disease control Recruiting nowThis study tests whether a higher dose of proton radiation can better control inoperable soft tissue sarcomas without increasing side effects. Forty adults with these rare tumors will receive targeted radiation over 4 weeks. Researchers will also look at blood and imaging markers…
Matched conditions: LEIOMYOSARCOMA (LMS)
Phase: PHASE2 • Sponsor: Oslo University Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
800-Patient study aims to tailor sarcoma treatment
Knowledge-focused Recruiting nowThis study is collecting tissue samples and medical data from 800 high-risk sarcoma patients to develop personalized treatment approaches. Researchers will analyze genetic and protein profiles to better predict which patients benefit from chemotherapy before surgery. The goal is …
Matched conditions: LEIOMYOSARCOMA (LMS)
Sponsor: Royal Marsden NHS Foundation Trust • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:08 UTC